Histone Deacetylase Inhibitor Givinostat Attenuates Nonalcoholic Steatohepatitis and Liver Fibrosis

By
Justin.choi
-
0
8
Researchers evaluated the therapeutic potential of givinostat, a histone deacetylase inhibitor, in the treatment of nonalcoholic steatohepatitis in vivo and in vitro.
[Acta Pharmacologica Sinica]

Sorry, but the selected Zotpress account can't be found.

Abstract